Metraipolis › archive › dc_cef1cb20d42b

Diroximel Fumarate-Loaded Solid Lipid Nanoparticles (DRF-SLNs) as Potential Carriers for the Treatment of Multiple Sclerosis: Preformulation Study — Europe PMC PMID:41465257

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41465257
DOI
10.3390/ijms262411827
License (as archived)
solo-consultazione
Archived
2026-11-07T21:05:36.818Z
SHA-256 of the archived text
45418a76cb23516040eae0d4cd6e1a58b56d791ceea851d94feb91eea0c291c2
Stable URL of this page
https://metraipolis.com/documento/dc_cef1cb20d42b

How to cite

Diroximel Fumarate-Loaded Solid Lipid Nanoparticles (DRF-SLNs) as Potential Carriers for the Treatment of Multiple Sclerosis: Preformulation Study — Europe PMC PMID:41465257 — Europe PMC (en), https://europepmc.org/article/MED/41465257 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cef1cb20d42b (Metraipolis archive dc_cef1cb20d42b, sha256 45418a76cb23516040eae0d4cd6e1a58b56d791ceea851d94feb91eea0c291c2)
BibTeX
@misc{dccef1cb20d42b,
  title = {Diroximel Fumarate-Loaded Solid Lipid Nanoparticles (DRF-SLNs) as Potential Carriers for the Treatment of Multiple Sclerosis: Preformulation Study — Europe PMC PMID:41465257},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41465257},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cef1cb20d42b; sha256 45418a76cb23516040eae0d4cd6e1a58b56d791ceea851d94feb91eea0c291c2},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41465257. Agents can read the archived copy with the MCP tool read_document.